Abstract

To explore the value of CT-based radiomics in differential diagnosis of retroperitoneal neuroblastoma (NB) and ganglioneuroblastoma (GNB) in children. A total of 172 children with NB and 48 children with GNB were assigned into the training set and testing set at the ratio of 7∶3 using a random stratified sampling method. Radiomics features were extracted and selected from non-enhanced and post-enhanced CT images. Based on the subset of optimal features, a multivariate regression model was used to establish the radiomics models for each phase and the combined radiomics models. The ROC curves of the models were drawn, and the evaluation indexes such as AUC, accuracy, sensitivity and specificity of these models were calculated and compared. A total of 1218 radiomics features were extracted from the CT images acquired in non-enhanced (NP), arterial (AP) and venous phases (VP), from which 4 features from the NP model, 3 features from the AP model, 2 features from the VP model and 5 features from the combined model were selected. The AUC of the NP model in the training set and testing set was 0.840 (95% CI: 0.778-0.902) and 0.804 (95% CI: 0.699-0.899), respectively, as compared with 0.819 (95%CI: 0.759-0.877) and 0.815 (95%CI: 0.697-0.915) for the AP model, 0.730 (95%CI: 0.649-0.803) and 0.751 (95%CI: 0.619-0.869) for the VP model, and 0.861 (95%CI: 0.809-0.910) and 0.827 (95%CI: 0.726-0.915) for the combined model. Radiomics signature based on non-enhanced and post-enhanced CT images can be helpful for distinguishing retroperitoneal NB and GNB in children. Compared with the first-order histogram features, textural features can better reflect the difference of the lesions. NP, AP and VP models have similar classification efficacy in differentiating retroperitoneal NB and GNB. The efficacy of the combined model is similar to that of the NP and AP models, but superior to that of the VP model.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call